ILC DOVER acquired by INGERSOLL RAND
Context
Ingersoll Rand has successfully finalized a definitive agreement to acquire 100% of ILC Dover from New Mountain Capital, marking a transformative expansion into the life sciences sector. This strategic transaction establishes a dedicated life sciences platform within the group’s Precision and Science Technologies (P&ST) segment, consolidating the target’s expertise with the group’s existing brands to create a $700 million revenue vertical. The strategic rationale for the move centers on the convergence of the target’s innovative single-use biopharma solutions with the group’s established liquid handling and positive displacement pump technologies. By incorporating the target’s established direct channels and deep connectivity with over 1,000 biopharma and medical device customers, the organization significantly increases its addressable market in highly fragmented growth segments. The partnership focuses on leveraging the group’s demand generation capabilities to drive cross-selling opportunities across its broader industrial product lines, such as specialized compressors and vacuum solutions. This integration reinforces the group’s position as a primary enabler of advanced medical therapy production and pharmaceutical innovation, providing the operational depth required to achieve high-single-digit returns on invested capital through standardized industrial excellence.
ILC DOVER, which reported an EBITDA margin of LOGIN in 2024, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the Industry & Manufacturing sector (11.0x).
Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.
-> Deep-dive in Industry & Manufacturing market trends
Target
ILC Dover is a premier technology organization dedicated to the design and production of highly innovative, mission-critical solutions for the biopharmaceutical, pharmaceutical, and medical device markets. The entity’s business model is centered on high-performance materials science, providing specialized powder and liquid single-use solutions that ensure sterility and safety in aseptic manufacturing processes. Its value proposition is anchored in a 75-year heritage of technical excellence, ranging from specialized rubber and silicone components for medical devices to life-support systems for the space industry. Strategically, the firm focuses on a "high-touch" engineering model, leveraging 11 global production facilities to serve a sophisticated client base across North America, Europe, and Asia. By maintaining a product portfolio where approximately 75% of revenue is derived from recurring or consumable streams, the organization ensures long-term operational stability. The organization operates as a critical infrastructure partner for enterprises navigating complex cell and gene therapy workflows and commercial drug production.
Ent. Value
LOGIN
Equity Value
LOGIN
Multiples
EV / Revenue
LOGIN
EV / EBITDA
LOGIN
EV / EBIT
LOGIN
Historical Financials (USD)
Similar deals in Industry & Manufacturing
| Date | Acquirer | Target | Country | Sector | Deal Context |
|---|---|---|---|---|---|
| 06/2024 | MIDDLEGROUND CAPITAL | L.S. STARRETT COMPANY | UNITED STATES | Industrial Equipment | The acquisition of The L.S. Starrett Company by MiddleGround Capital represents a significant take-private transaction in the industrial tools sector, concluding the company's 144-year history as a publicly-traded entity. Strategically, this move allows Starrett to transition from the quarterly pressures of the public markets to a private environment where it can focus on long-term operational flexibility and strategic capital deployment. The rationale for the investment centers on MiddleGround's intent to amplify Starrett's iconic brand status by scaling its geographic reach and diversifying its robust range of metrology and cutting tool offerings. The partnership aims to capitalize on key industrial trends, including the resurgence of advanced manufacturing and the reshoring of critical production to North America. Following the shareholder approval and delisting from the New York Stock Exchange, the company will benefit from MiddleGround’s deep operational expertise and financial backing to professionalize its global manufacturing footprint. |
| 04/2024 | TRITON PARTNERS | TRENCH GROUP | GERMANY | Industrial Equipment | Triton acquired the Trench business from Siemens Energy. The deal allows Siemens Energy to sharpen its portfolio while giving Trench the independence to invest in capacity expansion to meet the booming demand for grid infrastructure. Triton supported the carve-out and setup of standalone functions. |
| 03/2024 | ASTORG | STELIAU TECHNOLOGY | FRANCE | Industrial Equipment | Astorg has preempted the sale process of Steliau Technology to become its new majority shareholder, marking the company’s fourth LBO. Orchestrated by DDA & Cie, The transaction was financed via an unitranche debt structure, following the model of the previous LBO cycle. This strategic partnership is strictly engineered to accelerate Steliau's pan-European consolidation strategy, specifically targeting new entries into the German, UK, and Scandinavian markets to capitalize on the highly fragmented €3Bn European electronic distribution sector. |
| 02/2024 | IK PARTNERS | EUROFEU | FRANCE | Industrial Equipment | IK Partners, through its IK X Fund, has entered into exclusive negotiations to acquire a majority stake in Eurofeu, a leading player in the French fire protection market. IK is acquiring the stake from CAPZA and the management team, both of whom will be reinvesting to support the Group's next development phase. |
| 01/2024 | STANDARD BIOTOOLS | SOMALOGIC | UNITED STATES | Industrial Equipment | The merger between Standard BioTools and SomaLogic creates a diversified and scaled leader in the life sciences tools industry. The strategic rationale for this transaction centers on a "multi-omic integration" play, merging the target's technical operational depth in proteomics with the group's established mass cytometry and microfluidics platforms. This fusion effectively creates a specialized powerhouse capable of delivering clinical research insights with high throughput and data quality across approximately 50 countries. This operation allows the group to execute a definitive structural expansion of its commercial reach, leveraging substantial cross-selling opportunities between the target’s biopharmaceutical research footprint and the group’s academic research settings. By incorporating the target's innovative proteomic tools, the organization can now provide a more robust and integrated solution set for translational and clinical research. The maneuver optimizes the group's financial profile through the realization of significant cost synergies while utilizing a formidable capital structure to self-fund future growth initiatives. Ultimately, the partnership solidifies the group’s standing as a primary enabler of multi-omic innovation, bridging the gap between sophisticated laboratory-scale research and industrialized pharmaceutical development standards. |
| 12/2023 | ENPRO | ADVANCED MICRO INSTRUMENTS | UNITED STATES | Industrial Equipment | The successful acquisition of Advanced Micro Instruments (AMI) by Enpro Inc. marks a decisive tactical expansion of the group’s capabilities within the compositional analysis market. This transaction facilitates the integration of Advanced Micro Instruments' proprietary sensing technologies into Enpro Inc.’s Sealing Technologies segment, creating a broader portfolio of solutions for safeguarding critical environments. The strategic rationale hinges on the fusion of Advanced Micro Instruments’ gas analysis expertise with Enpro Inc.’s established reach in the midstream energy and industrial processing sectors. By incorporating Advanced Micro Instruments, Enpro Inc. reinforces its ability to address the increasing regulatory and environmental demand for methane emission reduction and biogas monitoring. The partnership is designed to leverage Enpro Inc.’s industrialized operating model to accelerate the scaling of Advanced Micro Instruments’ sensor portfolio across global markets. This integration facilitates the creation of a more robust technical platform, providing the strategic depth required to navigate the clean energy transition. The move solidifies Enpro Inc.’s standing as a primary provider of mission-critical instrumentation and environmental protection hardware. |
| 11/2023 | ATS CORPORATION | AVIDITY SCIENCE | UNITED STATES | Industrial Equipment | ATS Corporation has successfully finalized the acquisition of 100% of Avidity Science, integrating the entity into its growing Life Sciences platform. This strategic transaction is designed to establish a comprehensive suite of laboratory automation and water purification technologies, significantly enhancing the group's ability to serve global biomedical research facilities. The strategic rationale for the move centers on the high degree of technical complementarity between the target’s specialized water systems and the group's existing automation and fluid handling capabilities. By incorporating the target’s established customer base and proprietary filtration solutions, the organization bolsters its value proposition as a primary provider of mission-critical lab infrastructure. The partnership is focused on leveraging the group's global aftermarket service network to drive recurring revenue from consumables and maintenance services. This integration reinforces the organization’s standing as a leading enabler of technical innovation in the life sciences sector, providing the strategic depth required to support high-growth biopharmaceutical research and diagnostics applications worldwide. This move marks a significant densification of the group's presence in the scientific fluid management landscape. |
| 11/2023 | PATELEC GROUP | PHOENIX ELECTRONIC SYSTEM | ITALY | Industrial Equipment | Patelec Group has acquired a majority stake in Phoenix Electronic System to expand its product range into industrial wiring harnesses and electrical cabinets. The operation is meticulously structured to maintain the target's operational autonomy while deeply integrating its specialized product offerings to generate substantial cross-selling synergies. To effectively finance this major consolidation step, the acquirer utilized a specialized, medium-to-long-term ESG-linked debt facility provided by a major domestic bank, uniquely designed to reward the achievement of shared sustainability performance indicators. The primary strategic rationale underpinning this new partnership is to drastically accelerate cross-border expansion and broaden the combined entity's comprehensive portfolio of industrial electrical solutions. |
| 11/2023 | LIFCO | GREEN INSTRUMENTS | DENMARK | Industrial Equipment | Green Instruments has been acquired by Lifco. The strategic rationale for the move centers on the industrial synergy between Green Instruments' market-leading position in IMO-compliant monitoring systems and Lifco’s established expertise in scaling niche technical leaders through a decentralized operating model. This operation enable Lifco to reinforce its ability to address the increasing demand for high-reliability environmental monitoring driven by the maritime sector’s transition to carbon-neutral operations. The partnership is designed to leverage the group’s industrialized R&D resources and global presence to support the continued scaling of Green Instruments’ proprietary sensing portfolio across international shipping hubs. This integration facilitates the creation of a more robust environmental technology platform, providing the strategic depth required to navigate the maturing landscape of global maritime regulation. The move solidifies Lifco’s standing as a primary enabler of mission-critical emission transparency and industrial sustainability. |
| 11/2023 | OXFORD METRICS | INDUSTRIAL VISION SYSTEMS | UNITED KINGDOM | Industrial Equipment | The successful acquisition of Industrial Vision Systems Ltd by Oxford Metrics signals a significant tactical expansion of the group’s "sense, analyse and apply" strategy. This transaction facilitates the integration of specialized machine learning and AI-driven quality control software into Oxford Metrics’ broader smart sensing portfolio. The strategic rationale for the move centers on the fusion of Industrial Vision Systems Ltd's static vision technology with Oxford Metrics’ established expertise in dynamic sensing, creating a comprehensive platform for industrial automation. By onboarding this technical specialist, Oxford Metrics reinforces its ability to address the increasing demand for "right-first-time" manufacturing solutions among its blue-chip client base. The partnership is designed to leverage Oxford Metrics’ global reach and financial depth to scale Industrial Vision Systems Ltd's geographic footprint beyond the UK and Ireland. This integration facilitates the creation of a more robust smart manufacturing platform, providing the strategic resources required to navigate the maturing landscape of industrial AI. The move solidifies Oxford Metrics’ standing as a primary enabler of precision inspection and smart sensing innovation across global manufacturing sectors. |
REFERENCES
Valuation range: EV 1b - 4b USD
Revenue range: 250M - 500M USD
EBITDA range: 100M - 200M USD
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of ILC DOVER by INGERSOLL RAND are reserved for mynth community members. Register for free to unlock full data.
Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).
Target: ilc dover
Acquirer: ingersoll rand